Reference - Detail
| RRC ID | 44339 |
|---|---|
| Author | Niino S, Nakamura Y, Hirabayashi Y, Nagano-Ito M, Ichikawa S. |
| Title | A small molecule inhibitor of Bcl-2, HA14-1, also inhibits ceramide glucosyltransferase. |
| Journal | Biochem Biophys Res Commun |
| Abstract |
HA14-1 is a Bcl-2 inhibitor that is widely used for studies of apoptosis. In the course of searching for a ceramide glucosyltransferase inhibitor that catalyzes the first glycosylation step of glycosphingolipid synthesis, we unexpectedly found that HA-14-1 also has the ability to inhibit ceramide glucosyltransferase. The IC50 value of HA14-1 against ceramide glucosyltransferase is 4.5μM, which is lower than that reported for Bcl-2 in vitro. Kinetic analyses revealed that HA14-1 is a competitive and mixed-type inhibitor with respect to C6-NBD-ceramide and UDP-glucose, respectively. |
| Volume | 433(2) |
| Pages | 170-4 |
| Published | 2013-4-5 |
| DOI | 10.1016/j.bbrc.2013.02.052 |
| PII | S0006-291X(13)00312-4 |
| PMID | 23485465 |
| MeSH | 4-Chloro-7-nitrobenzofurazan / analogs & derivatives 4-Chloro-7-nitrobenzofurazan / pharmacology Animals Apoptosis / drug effects Benzopyrans / pharmacology* Cell Line Ceramides / metabolism Ceramides / pharmacology Drug Evaluation, Preclinical / methods Enzyme Inhibitors / pharmacology Glucosyltransferases / antagonists & inhibitors* Glucosyltransferases / metabolism Humans Inhibitory Concentration 50 Kinetics Melanoma, Experimental / drug therapy Melanoma, Experimental / metabolism Mice Nitriles / pharmacology* Proto-Oncogene Proteins c-bcl-2 / antagonists & inhibitors |
| IF | 2.985 |
| Times Cited | 4 |
| WOS Category | BIOPHYSICS BIOCHEMISTRY & MOLECULAR BIOLOGY |
| Altmetric score |
オルトメトリクス指標項目
|
| The most frequently cited source | Patent(IFI CLAIMS) |
| Total number of mentions | 3 |
| Altmetric score changes over past 6months | 0.0 |
| Resource | |
| Human and Animal Cells | B16 melanoma |